Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types

Duncan Hieu M Dam, Kayla S B Culver, Teri W Odom

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We report the design of a nanoconstruct that can function as a cell-type independent agent by targeting the ubiquitous protein nucleolin. Gold nanostars (AuNS) loaded with high densities of nucleolin-specific DNA aptamer AS1411 (Apt-AuNS) produced anticancer effects in a panel of 12 cancer lines containing four representative subcategories. We found that the nanoconstructs could be internalized by cancer cells and trafficked to perinuclear regions. Apt-AuNS resulted in downregulation of antiapoptotic Bcl-2 mRNA expression by ca. 200% compared to cells without the nanoconstructs. The caspase 3/7 activity (apoptosis) and cell death in cancer cells treated with Apt-AuNS increased by 1.5 times and by ca. 17%, respectively, compared to cells treated with free AS1411 at over 10 times the concentration. Moreover, light-triggered release of aptamer from the AuNS further enhanced the in vitro efficacy of the nanoconstructs in the cancer line panel with a 2-fold increase in caspase activity and a 40% decrease in cell viability compared to treatment with Apt-AuNS only. In contrast, treatments of the nanoconstructs with or without light-triggered release on a panel of normal cell lines had no adverse effects.

Original languageEnglish
Pages (from-to)580-587
Number of pages8
JournalMolecular Pharmaceutics
Volume11
Issue number2
DOIs
Publication statusPublished - Feb 3 2014

Fingerprint

Gold
Neoplasms
Nucleotide Aptamers
Caspase 7
Light
Protein Transport
Caspases
Caspase 3
Cell Survival
Cell Death
Down-Regulation
In Vitro Techniques
Apoptosis
Cell Line
Messenger RNA
nucleolin
AGRO 100

Keywords

  • anticancer agents
  • aptamers
  • gold nanostars
  • nucleolin

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types. / Dam, Duncan Hieu M; Culver, Kayla S B; Odom, Teri W.

In: Molecular Pharmaceutics, Vol. 11, No. 2, 03.02.2014, p. 580-587.

Research output: Contribution to journalArticle

@article{8f0196466f894e46b09c68776590a84c,
title = "Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types",
abstract = "We report the design of a nanoconstruct that can function as a cell-type independent agent by targeting the ubiquitous protein nucleolin. Gold nanostars (AuNS) loaded with high densities of nucleolin-specific DNA aptamer AS1411 (Apt-AuNS) produced anticancer effects in a panel of 12 cancer lines containing four representative subcategories. We found that the nanoconstructs could be internalized by cancer cells and trafficked to perinuclear regions. Apt-AuNS resulted in downregulation of antiapoptotic Bcl-2 mRNA expression by ca. 200{\%} compared to cells without the nanoconstructs. The caspase 3/7 activity (apoptosis) and cell death in cancer cells treated with Apt-AuNS increased by 1.5 times and by ca. 17{\%}, respectively, compared to cells treated with free AS1411 at over 10 times the concentration. Moreover, light-triggered release of aptamer from the AuNS further enhanced the in vitro efficacy of the nanoconstructs in the cancer line panel with a 2-fold increase in caspase activity and a 40{\%} decrease in cell viability compared to treatment with Apt-AuNS only. In contrast, treatments of the nanoconstructs with or without light-triggered release on a panel of normal cell lines had no adverse effects.",
keywords = "anticancer agents, aptamers, gold nanostars, nucleolin",
author = "Dam, {Duncan Hieu M} and Culver, {Kayla S B} and Odom, {Teri W}",
year = "2014",
month = "2",
day = "3",
doi = "10.1021/mp4005657",
language = "English",
volume = "11",
pages = "580--587",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types

AU - Dam, Duncan Hieu M

AU - Culver, Kayla S B

AU - Odom, Teri W

PY - 2014/2/3

Y1 - 2014/2/3

N2 - We report the design of a nanoconstruct that can function as a cell-type independent agent by targeting the ubiquitous protein nucleolin. Gold nanostars (AuNS) loaded with high densities of nucleolin-specific DNA aptamer AS1411 (Apt-AuNS) produced anticancer effects in a panel of 12 cancer lines containing four representative subcategories. We found that the nanoconstructs could be internalized by cancer cells and trafficked to perinuclear regions. Apt-AuNS resulted in downregulation of antiapoptotic Bcl-2 mRNA expression by ca. 200% compared to cells without the nanoconstructs. The caspase 3/7 activity (apoptosis) and cell death in cancer cells treated with Apt-AuNS increased by 1.5 times and by ca. 17%, respectively, compared to cells treated with free AS1411 at over 10 times the concentration. Moreover, light-triggered release of aptamer from the AuNS further enhanced the in vitro efficacy of the nanoconstructs in the cancer line panel with a 2-fold increase in caspase activity and a 40% decrease in cell viability compared to treatment with Apt-AuNS only. In contrast, treatments of the nanoconstructs with or without light-triggered release on a panel of normal cell lines had no adverse effects.

AB - We report the design of a nanoconstruct that can function as a cell-type independent agent by targeting the ubiquitous protein nucleolin. Gold nanostars (AuNS) loaded with high densities of nucleolin-specific DNA aptamer AS1411 (Apt-AuNS) produced anticancer effects in a panel of 12 cancer lines containing four representative subcategories. We found that the nanoconstructs could be internalized by cancer cells and trafficked to perinuclear regions. Apt-AuNS resulted in downregulation of antiapoptotic Bcl-2 mRNA expression by ca. 200% compared to cells without the nanoconstructs. The caspase 3/7 activity (apoptosis) and cell death in cancer cells treated with Apt-AuNS increased by 1.5 times and by ca. 17%, respectively, compared to cells treated with free AS1411 at over 10 times the concentration. Moreover, light-triggered release of aptamer from the AuNS further enhanced the in vitro efficacy of the nanoconstructs in the cancer line panel with a 2-fold increase in caspase activity and a 40% decrease in cell viability compared to treatment with Apt-AuNS only. In contrast, treatments of the nanoconstructs with or without light-triggered release on a panel of normal cell lines had no adverse effects.

KW - anticancer agents

KW - aptamers

KW - gold nanostars

KW - nucleolin

UR - http://www.scopus.com/inward/record.url?scp=84893318773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893318773&partnerID=8YFLogxK

U2 - 10.1021/mp4005657

DO - 10.1021/mp4005657

M3 - Article

VL - 11

SP - 580

EP - 587

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 2

ER -